Compatibility investigation for a new antituberculotic fixed dose combination with an adequate drug delivery.

作者: Valentina Petruševska , Kornelija Lasić , Ana Mornar

DOI: 10.1080/03639045.2020.1788066

关键词:

摘要: The compatibility of formulation components is crucial for safe and high-quality medicines. To detect the potential incompatibility to assess stability it beneficial condu...

参考文章(24)
D.J. Horne, C. Spitters, M. Narita, Experience with rifabutin replacing rifampin in the treatment of tuberculosis. International Journal of Tuberculosis and Lung Disease. ,vol. 15, pp. 1485- 1489 ,(2011) , 10.5588/IJTLD.11.0068
C.J Shishoo, S.A Shah, I.S Rathod, S.S Savale, M.J Vora, Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation International Journal of Pharmaceutics. ,vol. 228, pp. 53- 67 ,(2001) , 10.1016/S0378-5173(01)00831-6
Stephen R Byrn, Wei Xu, Ann W Newman, Chemical reactivity in solid-state pharmaceuticals: formulation implications Advanced Drug Delivery Reviews. ,vol. 48, pp. 115- 136 ,(2001) , 10.1016/S0169-409X(01)00102-8
Rajesh Singh Tomar, T.J. Joseph, A.S.R. Murthy, D.V. Yadav, G. Subbaiah, K.V.S.R. Krishna Reddy, Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms. Journal of Pharmaceutical and Biomedical Analysis. ,vol. 36, pp. 231- 235 ,(2004) , 10.1016/J.JPBA.2004.05.022
Vivek S. Dave, Suprit D. Saoji, Nishikant A. Raut, Rahul V. Haware, Excipient Variability and Its Impact on Dosage Form Functionality Journal of Pharmaceutical Sciences. ,vol. 104, pp. 906- 915 ,(2015) , 10.1002/JPS.24299
Bhagwat Prasad, Hemant Bhutani, Saranjit Singh, Study of the interaction between rifapentine and isoniazid under acid conditions. Journal of Pharmaceutical and Biomedical Analysis. ,vol. 41, pp. 1438- 1441 ,(2006) , 10.1016/J.JPBA.2006.03.004
Renu Chadha, Swati Bhandari, Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques. Journal of Pharmaceutical and Biomedical Analysis. ,vol. 87, pp. 82- 97 ,(2014) , 10.1016/J.JPBA.2013.06.016
Saji Thomas, Amber Bharti, Kalsang Tharpa, Ashutosh Agarwal, Quantification of potential impurities by a stability indicating UV-HPLC method in niacinamide active pharmaceutical ingredient. Journal of Pharmaceutical and Biomedical Analysis. ,vol. 60, pp. 86- 90 ,(2012) , 10.1016/J.JPBA.2011.10.033
M. H. Bickel, N-Oxide Formation and Related Reactions in Drug Metabolism Xenobiotica. ,vol. 1, pp. 313- 319 ,(1971) , 10.3109/00498257109041493
Qingfen Zhu, Tao Li, Jun Li, Ming Guo, Weijian Wang, Xiumei Zhang, In silico and in vitro genotoxicity evaluation of levofloxacin n-oxide, an impurity in levofloxacin. Toxicology Mechanisms and Methods. ,vol. 22, pp. 225- 230 ,(2012) , 10.3109/15376516.2011.635319